SCHEMBL1924464

SCHEMBL1924464

NC(=O)c1[nH]cc(CCC(=O)O)c1-c1ccc(NC(=O)Nc2ccc(F)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
STING1 Q86WV6 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TAAR1 Q96RJ0 1/20 0.37
KDR P35968 3/20 0.37
PDGFRB P09619 1/20 0.37
GPR17 Q13304 1/20 0.37
MAPT P10636 3/20 0.37
KIT P10721 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1925038 0.90 ROCK2 (0.46) MEN1KMT2AKDRPDGFRBMAPT
SCHEMBL1923912 0.89 KDR (0.48) KDM4EPOLBSTING1MEN1KMT2A
SCHEMBL1925334 0.88 EPHX2 (0.48) STING1CA12CA1CA2CA9
SCHEMBL1925337 0.88 PKM (0.47) ALDH1A1KDM4EPOLBPKMCA12
SCHEMBL1925039 0.86 RIPK1 (0.44) CA12CA1CA2CA9HTT
SCHEMBL1926602 0.86 KDM4E (0.46) KDM4EPOLBPKMCA12CA1
SCHEMBL1924884 0.86 MEN1 (0.42) POLBCA12CA1CA2CA9
SCHEMBL1925482 0.86 STING1 (0.44) ALDH1A1KDM4EPOLBSTING1HTT
SCHEMBL1924602 0.86 EPHX2 (0.49) PKMSTING1HTTMEN1KMT2A
SCHEMBL1926895 0.86 MAPT (0.41) KDM4EPOLBHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP claimed